Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 13 |
NetGPI | no | yes: 0, no: 13 |
Related structures:
AlphaFold database: A4I0P4
Term | Name | Level | Count |
---|---|---|---|
GO:0001510 | RNA methylation | 4 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006396 | RNA processing | 6 | 2 |
GO:0006399 | tRNA metabolic process | 7 | 2 |
GO:0006400 | tRNA modification | 6 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008033 | tRNA processing | 8 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009451 | RNA modification | 5 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0030488 | tRNA methylation | 5 | 2 |
GO:0032259 | methylation | 2 | 2 |
GO:0034470 | ncRNA processing | 7 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0034660 | ncRNA metabolic process | 6 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0043414 | macromolecule methylation | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 14 |
GO:0005488 | binding | 1 | 14 |
GO:0008168 | methyltransferase activity | 4 | 14 |
GO:0008171 | O-methyltransferase activity | 5 | 14 |
GO:0008173 | RNA methyltransferase activity | 4 | 14 |
GO:0008175 | tRNA methyltransferase activity | 5 | 14 |
GO:0016740 | transferase activity | 2 | 14 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 14 |
GO:0043167 | ion binding | 2 | 14 |
GO:0043169 | cation binding | 3 | 14 |
GO:0046872 | metal ion binding | 4 | 14 |
GO:0062105 | RNA 2'-O-methyltransferase activity | 5 | 14 |
GO:0106050 | tRNA 2'-O-methyltransferase activity | 6 | 14 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 14 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 14 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 14 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 164 | 166 | PF00675 | 0.497 |
CLV_NRD_NRD_1 | 233 | 235 | PF00675 | 0.277 |
CLV_NRD_NRD_1 | 352 | 354 | PF00675 | 0.445 |
CLV_NRD_NRD_1 | 396 | 398 | PF00675 | 0.503 |
CLV_PCSK_FUR_1 | 162 | 166 | PF00082 | 0.481 |
CLV_PCSK_KEX2_1 | 164 | 166 | PF00082 | 0.497 |
CLV_PCSK_KEX2_1 | 233 | 235 | PF00082 | 0.278 |
CLV_PCSK_KEX2_1 | 352 | 354 | PF00082 | 0.469 |
CLV_PCSK_KEX2_1 | 396 | 398 | PF00082 | 0.576 |
CLV_PCSK_PC7_1 | 229 | 235 | PF00082 | 0.307 |
CLV_PCSK_SKI1_1 | 229 | 233 | PF00082 | 0.323 |
CLV_PCSK_SKI1_1 | 260 | 264 | PF00082 | 0.336 |
CLV_PCSK_SKI1_1 | 57 | 61 | PF00082 | 0.373 |
CLV_PCSK_SKI1_1 | 77 | 81 | PF00082 | 0.345 |
CLV_Separin_Metazoa | 154 | 158 | PF03568 | 0.424 |
CLV_Separin_Metazoa | 275 | 279 | PF03568 | 0.523 |
DEG_SCF_FBW7_1 | 254 | 261 | PF00400 | 0.437 |
DOC_CKS1_1 | 255 | 260 | PF01111 | 0.437 |
DOC_CKS1_1 | 445 | 450 | PF01111 | 0.336 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 6 | 12 | PF00134 | 0.372 |
DOC_MAPK_gen_1 | 449 | 456 | PF00069 | 0.309 |
DOC_PP1_RVXF_1 | 244 | 251 | PF00149 | 0.523 |
DOC_PP2B_PxIxI_1 | 286 | 292 | PF00149 | 0.536 |
DOC_USP7_MATH_1 | 105 | 109 | PF00917 | 0.340 |
DOC_USP7_MATH_1 | 135 | 139 | PF00917 | 0.440 |
DOC_USP7_MATH_1 | 210 | 214 | PF00917 | 0.428 |
DOC_USP7_MATH_1 | 282 | 286 | PF00917 | 0.447 |
DOC_USP7_MATH_1 | 351 | 355 | PF00917 | 0.487 |
DOC_USP7_MATH_1 | 372 | 376 | PF00917 | 0.471 |
DOC_USP7_MATH_1 | 89 | 93 | PF00917 | 0.476 |
DOC_WW_Pin1_4 | 12 | 17 | PF00397 | 0.547 |
DOC_WW_Pin1_4 | 254 | 259 | PF00397 | 0.496 |
DOC_WW_Pin1_4 | 444 | 449 | PF00397 | 0.367 |
LIG_14-3-3_CanoR_1 | 233 | 239 | PF00244 | 0.499 |
LIG_14-3-3_CanoR_1 | 249 | 255 | PF00244 | 0.550 |
LIG_14-3-3_CanoR_1 | 328 | 334 | PF00244 | 0.561 |
LIG_14-3-3_CanoR_1 | 57 | 63 | PF00244 | 0.388 |
LIG_14-3-3_CterR_2 | 457 | 462 | PF00244 | 0.414 |
LIG_Actin_WH2_2 | 143 | 159 | PF00022 | 0.471 |
LIG_AP2alpha_2 | 206 | 208 | PF02296 | 0.365 |
LIG_APCC_ABBA_1 | 242 | 247 | PF00400 | 0.584 |
LIG_BIR_III_2 | 252 | 256 | PF00653 | 0.523 |
LIG_FHA_1 | 129 | 135 | PF00498 | 0.420 |
LIG_FHA_1 | 239 | 245 | PF00498 | 0.584 |
LIG_FHA_1 | 259 | 265 | PF00498 | 0.401 |
LIG_FHA_1 | 386 | 392 | PF00498 | 0.469 |
LIG_FHA_1 | 61 | 67 | PF00498 | 0.484 |
LIG_FHA_2 | 117 | 123 | PF00498 | 0.407 |
LIG_FHA_2 | 39 | 45 | PF00498 | 0.534 |
LIG_FHA_2 | 8 | 14 | PF00498 | 0.445 |
LIG_LIR_Gen_1 | 122 | 130 | PF02991 | 0.400 |
LIG_LIR_Gen_1 | 410 | 421 | PF02991 | 0.338 |
LIG_LIR_Nem_3 | 122 | 126 | PF02991 | 0.420 |
LIG_LIR_Nem_3 | 128 | 133 | PF02991 | 0.435 |
LIG_LIR_Nem_3 | 410 | 416 | PF02991 | 0.344 |
LIG_LIR_Nem_3 | 92 | 96 | PF02991 | 0.425 |
LIG_MYND_1 | 218 | 222 | PF01753 | 0.437 |
LIG_SH2_STAP1 | 130 | 134 | PF00017 | 0.336 |
LIG_SH2_STAP1 | 434 | 438 | PF00017 | 0.388 |
LIG_SH2_STAP1 | 96 | 100 | PF00017 | 0.400 |
LIG_SH2_STAT3 | 310 | 313 | PF00017 | 0.449 |
LIG_SH2_STAT5 | 130 | 133 | PF00017 | 0.370 |
LIG_SH2_STAT5 | 305 | 308 | PF00017 | 0.476 |
LIG_SH2_STAT5 | 310 | 313 | PF00017 | 0.472 |
LIG_SH2_STAT5 | 441 | 444 | PF00017 | 0.397 |
LIG_SH3_2 | 255 | 260 | PF14604 | 0.523 |
LIG_SH3_3 | 111 | 117 | PF00018 | 0.367 |
LIG_SH3_3 | 201 | 207 | PF00018 | 0.368 |
LIG_SH3_3 | 252 | 258 | PF00018 | 0.523 |
LIG_SH3_3 | 288 | 294 | PF00018 | 0.497 |
LIG_SH3_3 | 442 | 448 | PF00018 | 0.340 |
LIG_SUMO_SIM_par_1 | 125 | 132 | PF11976 | 0.390 |
LIG_SUMO_SIM_par_1 | 15 | 20 | PF11976 | 0.432 |
LIG_SUMO_SIM_par_1 | 29 | 35 | PF11976 | 0.385 |
LIG_WRC_WIRS_1 | 130 | 135 | PF05994 | 0.405 |
MOD_CDK_SPK_2 | 444 | 449 | PF00069 | 0.367 |
MOD_CDK_SPxK_1 | 254 | 260 | PF00069 | 0.437 |
MOD_CDK_SPxxK_3 | 444 | 451 | PF00069 | 0.401 |
MOD_CK1_1 | 15 | 21 | PF00069 | 0.446 |
MOD_CK1_1 | 354 | 360 | PF00069 | 0.554 |
MOD_CK1_1 | 385 | 391 | PF00069 | 0.537 |
MOD_CK2_1 | 116 | 122 | PF00069 | 0.380 |
MOD_CK2_1 | 336 | 342 | PF00069 | 0.460 |
MOD_CK2_1 | 7 | 13 | PF00069 | 0.409 |
MOD_GlcNHglycan | 107 | 110 | PF01048 | 0.402 |
MOD_GlcNHglycan | 270 | 273 | PF01048 | 0.323 |
MOD_GlcNHglycan | 354 | 357 | PF01048 | 0.478 |
MOD_GlcNHglycan | 371 | 375 | PF01048 | 0.390 |
MOD_GlcNHglycan | 38 | 41 | PF01048 | 0.416 |
MOD_GlcNHglycan | 384 | 387 | PF01048 | 0.471 |
MOD_GlcNHglycan | 397 | 400 | PF01048 | 0.421 |
MOD_GSK3_1 | 105 | 112 | PF00069 | 0.413 |
MOD_GSK3_1 | 234 | 241 | PF00069 | 0.491 |
MOD_GSK3_1 | 254 | 261 | PF00069 | 0.376 |
MOD_GSK3_1 | 332 | 339 | PF00069 | 0.508 |
MOD_GSK3_1 | 351 | 358 | PF00069 | 0.533 |
MOD_GSK3_1 | 36 | 43 | PF00069 | 0.439 |
MOD_GSK3_1 | 381 | 388 | PF00069 | 0.539 |
MOD_GSK3_1 | 395 | 402 | PF00069 | 0.547 |
MOD_GSK3_1 | 403 | 410 | PF00069 | 0.438 |
MOD_N-GLC_1 | 332 | 337 | PF02516 | 0.264 |
MOD_N-GLC_1 | 50 | 55 | PF02516 | 0.410 |
MOD_N-GLC_1 | 67 | 72 | PF02516 | 0.265 |
MOD_N-GLC_2 | 450 | 452 | PF02516 | 0.424 |
MOD_NEK2_1 | 129 | 134 | PF00069 | 0.501 |
MOD_NEK2_1 | 238 | 243 | PF00069 | 0.523 |
MOD_NEK2_1 | 268 | 273 | PF00069 | 0.492 |
MOD_NEK2_1 | 36 | 41 | PF00069 | 0.442 |
MOD_NEK2_1 | 370 | 375 | PF00069 | 0.451 |
MOD_NEK2_1 | 50 | 55 | PF00069 | 0.569 |
MOD_NEK2_2 | 332 | 337 | PF00069 | 0.539 |
MOD_PIKK_1 | 372 | 378 | PF00454 | 0.475 |
MOD_PKA_1 | 352 | 358 | PF00069 | 0.431 |
MOD_PKA_2 | 156 | 162 | PF00069 | 0.440 |
MOD_PKA_2 | 248 | 254 | PF00069 | 0.525 |
MOD_PKA_2 | 327 | 333 | PF00069 | 0.504 |
MOD_PKA_2 | 351 | 357 | PF00069 | 0.668 |
MOD_PKA_2 | 395 | 401 | PF00069 | 0.485 |
MOD_PKB_1 | 227 | 235 | PF00069 | 0.536 |
MOD_Plk_1 | 135 | 141 | PF00069 | 0.441 |
MOD_Plk_1 | 332 | 338 | PF00069 | 0.578 |
MOD_Plk_1 | 67 | 73 | PF00069 | 0.520 |
MOD_Plk_4 | 129 | 135 | PF00069 | 0.349 |
MOD_Plk_4 | 199 | 205 | PF00069 | 0.344 |
MOD_ProDKin_1 | 12 | 18 | PF00069 | 0.547 |
MOD_ProDKin_1 | 254 | 260 | PF00069 | 0.496 |
MOD_ProDKin_1 | 444 | 450 | PF00069 | 0.364 |
MOD_SUMO_rev_2 | 112 | 119 | PF00179 | 0.362 |
TRG_DiLeu_BaEn_1 | 122 | 127 | PF01217 | 0.369 |
TRG_DiLeu_BaLyEn_6 | 45 | 50 | PF01217 | 0.414 |
TRG_DiLeu_LyEn_5 | 122 | 127 | PF01217 | 0.369 |
TRG_ENDOCYTIC_2 | 130 | 133 | PF00928 | 0.359 |
TRG_ENDOCYTIC_2 | 423 | 426 | PF00928 | 0.305 |
TRG_ENDOCYTIC_2 | 96 | 99 | PF00928 | 0.413 |
TRG_ER_diArg_1 | 162 | 165 | PF00400 | 0.547 |
TRG_ER_diArg_1 | 227 | 230 | PF00400 | 0.471 |
TRG_ER_diArg_1 | 233 | 236 | PF00400 | 0.469 |
TRG_ER_diArg_1 | 45 | 48 | PF00400 | 0.385 |
TRG_Pf-PMV_PEXEL_1 | 278 | 283 | PF00026 | 0.336 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0NJE0 | Trypanosomatidae | 33% | 95% |
A0A3Q8IG18 | Leishmania donovani | 100% | 100% |
A0A3S7WY71 | Leishmania donovani | 53% | 90% |
A4HDB1 | Leishmania braziliensis | 77% | 100% |
A4I0P5 | Leishmania infantum | 53% | 90% |
D0A723 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 91% |
E9AIR1 | Leishmania braziliensis | 56% | 100% |
E9AWP4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
E9AWP5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 52% | 100% |
Q4QAS6 | Leishmania major | 52% | 100% |
Q4QAS7 | Leishmania major | 95% | 100% |
V5BR90 | Trypanosoma cruzi | 36% | 87% |